ReviewFrontiers in immunology2023

Immune checkpoint inhibitor-associated toxicity in advanced non-small cell lung cancer: An updated understanding of risk factors.

Xiangxiao Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.